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Abstract: The vision of multivalency as a strategy limited to achieve 
affinity enhancements between a protein receptor and its putative 
sugar ligand (glycotope) has proven too simplistic.  On the one hand, 
binding of a glycotope in a dense glycocalix-like construct to a lectin 
partner has been shown to be sensitive to the presence of a third 
sugar entity (heterocluster effect). On the other hand, several 
carbohydrate processing enzymes (glycosidases and 
glycosyltransferases) have been found to be also responsive to 
multivalent presentations of binding partners (multivalent enzyme 
inhibition), a phenomenon first discovered for iminosugar-type 
inhibitory species (inhitopes) and recently demonstrated for 
multivalent carbohydrate constructs. By assessing a series of homo 
and heteroclusters combining -D-glucopyranosyl-related glycotopes 
and inhitopes, here we show that multivalency and 
heteromultivalency govern indeed both kinds of events, allowing 
activating, deactivating or enhancing specific recognition 
phenomena towards a spectrum of lectin and glycosidase partners in 
a multimodal manner. This unified scenario originates from the ability 
of (hetero)multivalent architectures to trigger glycosidase binding 
modes that are reminiscent of those harnessed by lectins, which 
should be considered when profiling the biological activity of 
multivalent architectures. 
Introduction 
The saccharidic portion in glycoconjugates is involved in 
different binding-recognition processes that trigger or inhibit a 
wide variety of biological phenomena, including cell-cell 
communication, host-pathogen interactions, immune response 
or cancer metastasis, acting as information storage and 
transmission devices.[1] Although only a handful of 
monosaccharide subunits participate directly in the 
supramolecular events eliciting those responses, their multiple 
modes of combination results in an extremely versatile 
ensemble of readable arrangements that conforms the so-called 
“sugar code”.[2] Carbohydrate recognizing (lectins) and 
processing (glycosidases, glycosyltransferases) proteins can act 
as the complementary reader partners. The mechanism by 
which these two families of carbohydrate-interacting proteins 
interpret the information stored in the oligosaccharides is 
thought to be starkly different. Thus, glycosidases generally bind 
to single oligosaccharide sequences with high affinity and 
selectivity, which is followed by conformational distortion and 
enzymatic hydrolysis of the critical glycosidic linkage.[3] On the 
contrary, many lectins operate through multivalent interactions, 
typical monovalent carbohydrate ligands binding only weakly.[4] 
This dogma has largely dominated research on artificial 
glycosidase and lectin ligands through the last decades. Thus, 
many synthetic polyconjugates with various copies of an 
identical individual sugar recognition motif (glycotope) attached 
to a polymeric, dendritic or molecular scaffold have been 
developed aiming at mimicking and matching the arrangement 
of complementary lectin receptors in their natural mode of 
affinity enhancement.[5,6] The design of glycosidase inhibitors 
has focused instead on monovalent glycomimetics with a 
resemblance to the natural substrate or to the corresponding 
transition state.[7] 
The above doctrine has been seriously questioned by recent 
experimental evidences. On the one hand, it has been 
demonstrated that glycoheterogeneity has an impact on 
carbohydrate–protein recognition events,[8-12] a concept that has 
been termed “the heterocluster effect”.[13,14] On the other hand, 
clusterization of a carbohydrate-processing-enzyme inhibitory 
moiety (inhitope), generally an iminosugar-type glycomimetic, 
has been shown to modulate and eventually amplify the ability of 
inhibiting certain glycosidases[15-20] and glycosyltransferases,[21] 
a counterintuitive phenomenon named “multivalent enzyme 
inhibition” or “multivalent inhibition effect”.[22,23] Similarly to the 
classical multivalent or cluster effect operating in homogeneous 
glycoligand-lectin interactions, the heterocluster and multivalent 
inhibition effects depend on the interacting partners and on 
architectural parameters. More recently, it was found that -D-
glucopyranoside and -D-mannopyranoside glycotopes, which 
are specific ligands of lectins such as the plant lectin 
concanavalin A (ConA), the uropathogenic Escherichia coli lectin 
Fim-H or the dendritic cell-specific C-type lectin DC-SIGN,[6] 
become potent inhibitors of some glycosidases when 
(hetero)multivalently exposed at the surface of nanodiamonds 
(Figure 1 A), definitely blurring the boundaries between lectin 
and glycosidase recognition.[24] Further investigations using -D-
mannopyranoside-, -D-galactopyranoside-, -L-fucopyranoside- 
and -lactoside-fullerene conjugates (Figure 1 B) supported the 
new paradigm,[25] highlighting the urgent need for integrated 
studies on the consequences of (hetero)multivalency in the 
selectivity profile of glycotope/inhitope motifs not only towards 
one or more different lectins or one or more different 
glycosidases, but also towards a spectrum of lectin and 
glycosidase partners. 
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Figure 1. Schematic representation of heterovalent glyco-nanodiamonds (A) 
and homovalent glyco(mimetic)-fullerenes (B) showing dual lectin-glycosidase 
binding abilities. 
We have previously reported that the sp2-iminosugar-type[26] 
5N,6O-oxomethylidenenojirimycin (ONJ; Figure 1B) residue, a 
potent -glucosidase inhitope, is also a ligand of peanut (Arachis 
Hypogaea) agglutinin (PNA) lectin, enabling competitive assays 
that provide unique information on the binding modes elicited by 
multivalency. [17] In principle, the strategy can be also applied to 
glycoclusters with lectin binding and glycosidase inhibitory 
properties and, by extension, to mixed inhitope/glycotope 
heteromultivalent constructs, offering an excellent opportunity to 
investigate the molecular basis of the effects triggered by 
(hetero)multivalency in both types of proteins. As a proof of 
concept, we have now synthesized a series of 
cyclomaltoheptose (-cyclodextrin, CD) conjugates 
incorporating ONJ and/or -D-glucopyranoside (-Glc) moieties 
intentionally designed to pinpoint analogies/differences in 
recognition processes against lectins and glycosidases. First, we 
have evaluated the impact of (hetero)multivalency in PNA/ONJ 
and ConA/-Glc binding. Second, we determined the effect of 
(hetero)multivalency in the inhibition of maltase (yeast) 
isomaltase (yeast) and -mannosidase (Jack bean). The three 
are multivalency-sensitive enzymes, but whereas the catalytic 
site of -mannosidase is rather accessible and can host inhitope 
moieties at the periphery of multivalent inhibitors, maltase and 
isomaltase possesses deep catalytic sites that can hardly be 
access by ligands scaffolded in nanosized platforms.[17,25] 
Lectin/lectin and lectin/glycosidase cross-linking experiments in 
the absence or presence of reference ligands have been 
additionally conducted to identify binding modes and provide a 
rational for the observed multimodal effect of 
(hetero)multivalency in lectin recognition and glycosidase 
inhibition. The ensemble of data incite the conceptualization of 
(hetero)multivalency as a tool to administer the information 
encoded in glyo(mimetic) devices in a much broader context that 
previously thought. 
 
Results and Discussion 
Glyco(mimetic)cluster Library Design 
The facial anisotropy of the CD macroring and the availability of 
a variety of efficient selective chemical functionalization 
methodologies make CD-scaffolded glycol(mimetic)clusters 
privileged architectures to assess the effect of the relative 
density and orientation of ligands in the interaction with 
complementary biomolecular partners.[27] In order to get 
information on the effect of primary structure (i.e., the nature and 
number of copies of the ligands) and secondary structure (i.e., 
their spatial arrangement) modifications on the glycosidase and 
lectin recognition properties, the library of glyco(mimetic) 
clusters 1-12 was synthesized (Figure 2).  
 
Figure 2. Structures of the glycotope (-Glc)/inhitope (ONJ) conjugates 
prepared in this work and schematic representation of their different topologies 
(A-C). 
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Conjugates 1-4 are monovalent controls; their comparative 
assessment should allow establishing the effect of the CD 
scaffold in the recognition of the glycotope (-Glc) or inhitope 
(ONJ) motif by protein partners. Interrogation of the heptavalent 
(5-7; including the hemi-substituted derivative 8) and 
tetradecavalent (9-12) sublibraries will provide information on 
the influence of multivalency and heteromultivalency in a face-
oriented, relatively compact arrangement (Figure 3, structure A) 
or in a quasi-globular distribution of the coating recognition 
elements (Figure 3, structures B and C), respectively. Note that 
whereas the heterovalent constructs 7 and 11 expose statistic 
(“shuffled”) 1:1 distributions of the glycotope and inhitope 
moieties in separate branches, compound 12 is a single isomer 
derivative bearing a -Glc and a ONJ motif in every arm; it was 
purposely incorporated in our study to evaluate the potential 
influence of orientational factors in the behavior of high-density 
heteroclusters against lectins and glycosidases. 
Impact of (hetero)multivalency in lectin binding 
The relative lectin binding abilities of compounds 1-12 against 
the lectins ConA and PNA were evaluated using a competitive 
enzyme-linked lectin assay (ELLA).[6] Briefly, the fraction of 
horseradish-labelled lectin (HRP-ConA or HRP-PNA) bound to a 
microplate-supported reference ligand (yeast mannan or a 
galactose-coated glycopolymer, respectively) in the absence 
and presence of increasing concentrations of the new 
conjugates was monitored. The concentrations needed to 
achieve 50% inhibition of the reference ligand-lectin association 
(IC50 values; assumed to be proportional to the corresponding 
binding energies) are collected in Table 1. The IC50 values 
obtained for methyl -D-mannopyranoside (1050±50 M) and 
methyl -D-glucopyranoside (11000±100 M) against ConA and 
for lactose against PNA (1350±10M) under the same 
experimental settings were consistent with values reported in the 
literature,[24,28,29]  validating the method and providing a 
reference for the analysis of the impact of structure modifications 
in the stability of the ligand-lectin complex. 
The ELLA data for homogeneous series of -Glc 
homoconjugates against ConA reflected the expected trend 
dictated by the known lectin selectivity and the classical 
multivalent effect. Thus, the monovalent -Glc derivatives 2 and 
4 show IC50 values that are close to that of methyl -D-
glucopyranoside (11000±100 M), with relatively short 
differences that are ascribable to aglycon effects. The IC50 value 
for the CD conjugate 4 (9050 mM) has been taken as a 
reference for determination of relative potencies (RP) of binding 
to ConA and normalized relative potencies in -Glc molar basis 
(NRP), which allows a comparative evaluation of the multivalent 
effect . Thus, the hepta- and tetradeca-valent homologues 6 and 
10 exhibit RP (NRP) values of 35 (5) and 323 (23), meaning that 
the -Glc glycotope is recognized with 5-fold higher efficiency 
when going from valency 1 to valency 7 and that the efficiency 
further increases by 23-fold when going to valency 14 (Table 1) 
   
Table 1. IC50 (M), relative potency (RP) and normalized relative potency 
(NRP) values for the inhibition of binding of HRP-ConA[a] or HRP-PNA[b] to a 
microtiter-anchored reference ligand by compounds 1-12 in competitive ELLA. 
 HRP-ConA HRP-PNA 
Comp. IC50 
(M) 
RP 
(folds)[c] 
NRP 
(folds)[d] 
IC50 
(M) 
RP 
(folds)[e] 
NRP 
(folds)[f] 
1 n.i.[g] n.i. n.i. 3100±50 1.0 1.0 
2 7450±60 1.2 1.2 n.i. n.i. n.i. 
3 n.i. n.i. n.i. n.i. n.i. n.i. 
4 9050±90 1.0 1.0 n.i. n.i. n.i. 
5 n.i. n.i. n.i. n.i. n.i. n.i. 
6 260±25 34.8 5.0 n.i. n.i. n.i. 
7 340±25 26.6 7.6 n.i. n.i. n.i. 
8 n.i. n.i. n.i. n.i. n.i. n.i. 
9 n.i. n.i. n.i. 10±2 310 22.1 
10 28±2 323 23.0 n.i. n.i. n.i. 
11 42±4 215 30.7 19±2 163 23.3 
12 88±2 103 15.7 n.i. n.i. n.i. 
[a] Methyl -D-mannopyranoside and methyl -D-glucopyranosides afforded 
IC50 values of 1050±50 and 11000±100 M in a parallel assay. [b] Lactose 
afforded an IC50 value of 1350±10M in a parallel assay. [c] Referred to the 
CD-linked monovalent control 3. [d] In -Glc molar basis. [e] Referred to the 
monovalent control 1. [f] In ONJ molar basis. [g] No inhibition detected at 
concentrations up to 5 mM. 
   
The binding behaviour of homomultivalent ONJ sp2-
iminosugar clusters towards PNA lectin can be similarly 
rationalized assuming a glycoligand-like behaviour. Indeed, 
although PNA is generally considered a galactose-binding lectin, 
glycopolymers and glycoclusters incorporating glucopyranosyl 
moieties with nitrogen functionalities at the primary position, 
structurally related to the ONJ motif, have been also shown to 
exhibit affinity towards PNA.[30] Such recognition capabilities are 
only elicited after reaching a critical monomer density, which in 
the present case requires incorporation of the glycomimetic at 
both CD faces in 14-valent conjugates. Thus, whereas no PNA 
recognition could be evidenced for the primary-face ONJ 
clusters 5 and 8 even at relatively high (5 mM) concentration, 
the corresponding IC50 value for 9 (10±2 M) represents a RP of 
310 taken the monovalent derivative 1 as the reference, 
meaning a NRP of 22.1 in ONJ molar basis, a quite significant 
multivalent effect (Table 1). 
Heterogeneity had a remarkable impact in ConA 
recognition, which is particularly evident when comparing the 
NRP values for -Glc homoclusters 6 and 10 (5 and 23) with the 
corresponding values for ONJ/-Glc heteroclusters 7, 11 and 12 
(NRP 7.6, 30.7 and 15.7, respectively). The data are indicative 
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of a 50% enhancement in the relative binding potency (-Glc 
molar basis) when half of the -Glc glycotopes in 6 are replaced 
by ONJ moieties, a motif that is not a ligand for ConA. In the 
case of 12 and 11 the per-glucose affinity enhancements relative 
to 6 reach 310% and over 600%, respectively. Regarding PNA, 
the combined display of ONJ and -Glc units on the primary 
face of the CD platform in 7 and 12 does not lead to functional 
ligands of this lectin, as also occurred for homocluster 5. 
Heterocluster 11 keeps a binding affinity almost identical to that 
of the homogeneous ONJ homologue 9 when normalized to 
ONJ molar basis (NRP 23.3). Note, however, that this result 
means that efficient conjugate-lectin recognition was elicited with 
just half of the ONJ ligand density (Table 1). Control 
experiments discarded cross-selectivity between homogeneous 
-Glc glycoclusters (6, 10) and PNA or homogeneous ONJ 
conjugates (5, 8, 9) and ConA. The nonlinear behaviour 
observed for heterogeneous architectures must thus be 
interpreted in terms of synergistic cooperativity between binding 
and nonbinding motifs, which represents the first evidence of a 
glycotope/inhitope heterocluster effect. 
Impact of (hetero)multivalency in glycosidase inhibition 
Although the monovalent -glucopyranosides 2 and 4 are 
substrates of the -glucosidases maltase and isomaltase, 
control experiments showed that the -Glc moieties displayed at 
the periphery of CD-centered homo (6, 10) or heteromultivalent 
derivatives (7, 11, 12) were not susceptible to hydrolysis by any 
of these two enzymes (gas chromatography monitoring). All 
monovalent and (hetero)multivalent -Glc conjugates remained 
also unmodified after incubation with -mannosidase, as 
expected from the mismatching configurational relationship. 
Alterations in substrate hydrolysis kinetics in their presence must 
then be ascribed to interactions with the enzyme but not to 
substrate-like behavior. The inhibition constants (Ki) values of 
the whole compound library 1-12 against maltase, isomaltase 
and -mannosidase are collected in Table 2. 
  
Table 2. Ki values [M] of the mono (1-4) and 
(hetero)multivalent CD  glyco(mimetic)clusters (5-12).[a] 
 Ki values (M)[b] 
Compound Maltase Isomaltase -Mannosidase 
1 2.6±0.1 5.1±0.2 596±10 
2 n.d.[c] n.d. n.i.[d] 
3 53±3 61±3 n.i. 
4 n.d. n.d. n.i. 
5 2.9±0.1 1.9±0.1 23.0±0.5 
6 n.i. n.i. 590±12 
7 1.4±0.1 1.4±0.1 506±10 
8 40±3 65±5 35±2 
9 1.7±0.1 2.0±0.1 2.5±0.2 
10 524±15 326±10 351±10 
11 4.2±0.3 5.6±0.3 70±6 
12 0.82±0.05 1.6±0.1 5.1±0.3 
[a] Inhibition was competitive in all cases. [b] Results in 
triplicate were used for determination of Ki values; the 
corresponding standard deviations are indicated. [c] Not 
determined. [d] No inhibition was observed at 1 mM 
concentration (Ki>1000 M). 
  
We have previously provided evidence supporting that  
most of the binding energy of mono and multivalent inhibitors to 
-mannosidase arise from interactions involving the same region 
in the protein, namely the aglycon (1) site in the catalytic 
pocket.[17,25] This situation is analogous to that generally 
encountered in carbohydrate-lectin recognition events. 
Consequently, the relative inhibition potency (RIP) enhancement 
on moving from the monovalent reference (1) to 
(hetero)multivalent analogues (determined as the quotient 
between the corresponding Ki values in Table 2), normalized on 
per-ONJ molar basis (NRIP), is a good indication of the 
inhibitory multivalent effect intensity (Table 3). On the contrary, 
in the case of maltase or isomaltase monovalent and 
(hetero)multivalent inhibitors are expected to target different 
sites in the protein: monovalent inhibitors locate at the aglycone 
site whereas multivalent partners probably block access to the 
catalytic site by attaching at non-glycone regions.[17,25]  This 
scenario prevents a similar approach for comparative evaluation 
of potential (hetero)multivalent effects. Control experiments 
indicated that homocluster 8, with a 3.5 nominal valency, is the 
lowest-valency ONJ derivative in the series exhibiting the non-
glycone binding mode. For normalization purposes, we have 
considered that the Ki values measured for 8 against maltase 
and isomaltase (40 and 65 M, respectively; Table 2) 
correspond, formally, to 3.5-folds the inhibitory potency of a 
single ONJ unit interacting at the same enzyme region. Note that 
this would imply a mere statistic effect for 8. Although we are 
aware that this assumption underestimates multivalent effects 
when considering absolute RIP/NRIP values, it provides a good 
basis for comparison. The corresponding calculated RIP and 
NRIP values for the ensemble of hetero(multivalent) conjugates 
are collected in Table 3. 
     
Table 3. Relative inhibition potency (RIP; folds) and normalized relative 
inhibition potency (NRIP; folds) values for the inhibition of yeast maltase and 
isomaltase and Jack bean -mannosidase by (hetero)multivalent CD  
glyco(mimetic)clusters 5-12. 
Compound Maltase Isomaltase -Mannosidase
 RIP[a] NRIP[b] RIP[c] NRIP[b] RIP[d] NRIP[b] 
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5 48.2 6.9 119 17 25.9 3.7 
6 n.i.[e] n.a.[f] n.i. n.a. 1 n.a. 
7 100 28.6 162 46.3 1.2 0.34 
8 3.5 1 3.5 1 17 4.8 
9 82 5.9 113 8.1 238 17 
10 0.27 n.a. 0.7 n.a. 1.7 n.a. 
11 33.3 4.8 40.5 5.8 8.5 1.2 
12 171 24.4 142 20.3 117 16.7 
 [a] Referred to the formal contribution of each ONJ motif in 8 to the 
inhibition potency against maltase (Ki 140 M). [b] In ONJ molar basis. [c] 
Referred to the formal contribution of each ONJ motif in 8 to the inhibition 
potency against isomaltase (Ki 227 M). [d] Referred to the monovalent 
reference control 1 (Ki 596 M). [e] No inhibition was observed at 1 mM 
concentration (Ki>1000 M). [f] Do not apply. 
     
Maltase and isomaltase exhibited analogous inhibition 
susceptibility trends when profiled against 1-12. The monovalent 
ONJ control 1 is a potent inhibitor of both enzymes (Ki 2.6 and 
5.1 M, respectively). The inhibitory potency decreases by 
above 10-fold when the inhitope is connected to the CD scafold 
(3; Ki 53 and 61 M), probably due to unfavourable steric 
contacts between the cyclooligosaccharide and the proteins 
upon hosting the glycomimetic at the active site. In apparent 
contradiction, the much bigger multiconjugates 5, 7, 9, 11 and 
12 behaved as low M-to-nM inhibitors. Homovalent -Glc-
coated glycoclusters were either no (6) or very weak (10) 
inhibitors (Table 2). The optimal per-ONJ efficiency among 
homoconjugates is reached for the heptavalent derivative 5, with 
NRIP values of 6.9 and 17 for maltase and isomaltase, 
respectively. Remarkably, the simultaneous presentation of ONJ 
(inhibitory) and -Glc (non-inhibitory) motifs in 7 further boosted 
the inhibitory potency, with NRIP values scaling up to 28.6 and 
46.3. In other words, each ONJ inhitope in heterocluster 7 is 
recognized 4-fold (for maltase) or 2.7-fold (for isomaltase) more 
effectively that in homovalent cluster 5, with an overall 
analogous architecture, which represents the first evidence of a 
heteromultivalent inhibitory effect. A similar synergistic action is 
observed in the case of compound 12 (NRIP 24.4 and 20.3 
against maltase and isomaltase): both homocluster 5 and 
heterocluster 12 expose seven ONJ moieties at the primary CD 
rim, but the simultaneous presence of seven -Glc moieties in 
12 translates into significantly higher inhibitory potencies (Table 
3). 
The monovalent control 1 was instead a very poor inhibitor 
of Jack bean -mannosidase (Ki 596 M) and the corresponding 
CD conjugate 3 showed no measurable inhibition at 1 mM 
concentration. In sharp contrast, the hepta- and tetradecavalent 
glycomimetic homoclusters 5 and 9 behaved as strong inhibitors 
of the enzyme, with Ki values of 23 and 2.5 M, respectively 
(Table 2). The bouquet-type tetradecavalent ONJ homocluster 9 
showed the highest multivalent inhibitory effect, with a RIP of 
238, corresponding to a NRIP (ONJ molar basis) of 17. To our 
surprise, the combined presentation of ONJ and -Glc 
substituents in 11 was strongly detrimental for-mannosidase 
inhibition (NRIP 1.2-fold). An even more dramatic antagonistic 
effect was observed when comparing the primary rim-substituted 
homoconjugates 5 or 8 (NRIP 3.8 4.8) with heteroconjugate 7 
(NRIP 0.34). Interestingly, compound 12, with the same total 
and partial valencies than 11, turned out to be a much potent 
inhibitor of -mannosidase (Ki 5.1 M), meaning a NRIP of 16.7, 
about five-fold higher as compared with the homo-heptavalent 
derivative 5 (Table 3), suggesting that architectural parameters 
can significantly impact multivalent and heteromultivalent 
inhibition of -mannosidase. 
The ensemble of lectin binding and glycosidase inhibition 
data clearly illustrates that (hetero)mutlivalency affects 
simultaneously and in different manners both types of events. 
Although the inhibition potency enhancements observed for 
homomultivalent ONJ conjugates suggest that similar 
mechanisms may operate in multivalent enzyme inhibition and in 
glycocluster-lectin binding, the much higher sensitiveness of the 
enzymes to heteromultivalency points to significant differences 
in the binding modes that need to be investigated. To get 
information on this aspect, different cross-linking assays were 
next conducted. 
Impact of (hetero)multivalency in lectin cross-linking 
abilities: Preferred lectin binding modes 
 Although both ConA and PNA are tetramers at the close-
to-neutral pH used in ELLA,[31,32] the presence of the voluminous 
HRP-tag disable lectin cross-linking and chelate-type binding 
modes. Essentially, the IC50 data in Table 1 originate from 
interactions of the glyco(mimetic) ligands with a single binding 
site in the lectin.[33] The relative cross-linking potential of the 
homo and heterovalent conjugates was assessed by two-site 
(sandwich-type) ELLA experiments. In this case, the ability of 
the glycoligands to bridge the HRP-labelled lectin in the solution 
and unlabelled (therefore cross-linkable) lectin fixed in the plate 
is determined.[34] As expected, the 14-valent -Glc glycocluster 
10 exhibited the highest ConA cross-linking potential, which was 
set at 100% for a 500 M concentration. The rest of homo- or 
heterovalent -Glc-displaying conjugates exhibited relative 
cross-linking abilities that followed their lectin binding efficacy, 
i.e. 10 > 11 > 12 > 6 > 7 (Figure 3 A). A similar two-site ELLA 
test using PNA and HRP-PNA let confirm the cross-linking 
potential of the two-face ONJ-displaying clusters 9 and 11 
(Figure 3 B). 
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Figure 3.  Relative ConA (A) and PNA (B) cross-linking capability plots of -
Glc/ONJ homo and heteromultivalent conjugates determined by two-site ELLA. 
Analogous ConA cross-linking experiments conducted in 
the presence of excess of mono or homomultivalent ONJ 
conjugates (1, 3, 5, 9; 500 M) led to virtually superimposable 
plots to those shown in Figure 3 A. Reciprocally, the presence of 
mono or homomultivalent -Glc conjugates (2, 4, 6, 10; 500 M) 
did not alter the PNA cross-linking plots for the homovalent ONJ 
derivative 9 or the heterovalent analogue 11 shown in Figure 3 B. 
These results discard the presence of secondary sites for ONJ 
in ConA or for -Glc in PNA that could promote a “carbohydrate 
module effect” mechanism, as proposed for 
heteroglycopolymers targeting different subsites in 
oligosaccharide binding lectins (Figure 4 A).[35] Two alternative 
mechanistic hypotheses have been advanced to account for the 
lectin affinity enhancement promoted for nonbinding sugar 
epitopes in heteromultivalent systems, namely entropically-
driven stabilisation of lectin-heterocluster complexes through 
assisted sliding of the putative glycotopes over the binding site[8] 
(Figure 4 B) or induction of a favourable orientation of the 
binding motifs resulting in steric shielding and an overall 
increased in affinity[11] (Figure 4 C). The latter scenario is 
expected to penalize significantly the lectin bridging capabilities 
of the heteroconjugates as compared to homoconjugates. 
Although the two-site ELLA plots (Figure 3) revealed a moderate 
depletion of the lectin cross-linking efficiency for heteroclusters, 
compounds 7, 11 and 12 still keep substantial ConA cross-
linking potential, as well as 11 against PNA,  suggesting that 
both mechanisms, assisted sliding and steric shielding, may 
operate simultaneously in these systems. 
 
Figure 4. Schematic representation of the three possible mechanisms 
advanced to account for the heterocluster effect: (A) the presence of high and 
low affinity binding sites in the lectin for different carbohydrate modules 
(carbohydrate module effect), (B) entropic stabilization of the heteromultivalent 
ligand-lectin complex by fast sliding processes, and (C) conformational 
preorganization of the binding motif and steric shielding leading to higher 
binding affinity. Grey and black balls represent ONJ and -Glc substituents, 
respectively. The primary binding site in the lectin is highlighted in black. The 
experimental data support that the two later mechanisms may simultaneously 
act for the CD-centred heteromultivalent clusters in this study. 
Competitive lectin-glycosidase binding assays: Mapping 
(hetero)multivalent glycosidase binding modes 
The capability of several of the CD-scaffolded 
glyco(mimetic)clusters evaluated in this work of simultaneously 
cross-linking lectins and inhibiting glycosidases enables a 
competitive assay in which the efficiency of the tested enzyme to 
sequester the ligand, therefore preventing complementary lectin 
clustering, is monitored in the absence and in the presence of 
inhibitors of the enzyme.[17,25] By using inhibitors targeting the 
glycone and/or aglycone sites in the glycosidase, the 
involvement of these regions in binding to the (hetero)multivalent 
conjugate can be mapped (Figure 5). 
 
Figure 5. Schematic representation of the enzyme-lectin competitive assay 
configuration. In the absence of a third species, an equilibrium between the 
enzyme/ligand complex (A) and the lectin-HRP/ligand (B) is established in the 
solution phase; as the concentration of the enzyme increases, the available 
ligand to cross-link the lectin anchored in the microplate decreases, which can 
be evaluated in a two-site ELLA. In the presence of an enzyme inhibitor, 
formation of the corresponding enzyme-inhibitor complex (D-F) will compete 
with formation of complex A, and the lectin cross-linking potential will be 
enhanced. By employing inhibitors occupying the glycone site (D), 
simultaneously the glycone and aglycone sites (E) or a wider enzyme surface 
(F), the biding mode of the tested ligand can be probed. 
In the case of the ONJ homocluster 9, its potential to 
cross-link PNA (in the microplate) and HRP-PNA (in the 
solution) at 125 M concentration, as determined in the two-site 
ELLA experiment (Figure 3 B; set at 100%), experienced a 
hyperbolic decrease with increasing concentrations of maltase 
or -mannosidase. This is in agreement with the existence of a 
reversible exchange of the multivalent compound between the 
two protein species in the solution phase. An identical 
experiment carried out for maltase in the presence of three 
different concentrations of the sp2-iminosugar-type glycomimetic 
13,[36] a glycone-type inhibitor of this enzyme, showed a very 
minor alteration of the above equilibrium (Figure 6 A), strongly 
supporting that the glycone (1) catalytic site is only marginally 
participating, if any, in the stabilisation of the 9:maltase complex. 
In sharp contrast, the pseudodisaccharide inhibitor 14,[37] which 
simultaneously occupies the glycone (1) and aglycone (+1) 
D
E
F
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sites of maltase, or the multivalent inhibitor 5 (which does not 
cross-link PNA but binds to maltase) almost completely restored 
the lectin clustering capabilities (Figure 6 B and C). Analogous 
PNA/-mannosidase competitive experiments were conducted 
in the absence and presence of glycone (15),[38] 
glycone/aglycone (16)[17] and multivalent (5) inhibitors of -
mannosidase that are not ligands of the lectin (Figure 6 D-F). 
The glycone-type inhibitor 15 was already able to very 
significantly re-establish the PNA cross-linking capabilities of 9 
to a very significant extent (Figure 6 D), highlighting its decisive 
implication in multivalent -mannosidase inhibition. 
 
Figure 6. Plots of the inhibition of the PNA–HRP-PNA cross-linking mediated 
by the ONJ CD homocluster 9 in two-site ELLA tests by increasing amounts 
of maltase (A-C) or -mannosidase (D-F). Data were collected in the absence 
and presence of 100, 250 or 500 M concentrations of the aglycon-type 
inhibitors 13 or 15 (A and D), the glycone/aglycone-type inhibitors 14 or 16 (B 
and E), or the multivalent inhibitors 5 (C and F). Each point represents the 
mean of three independent determinations (S.D. 12–18%). 
Identical assays were completed for the rest of 
(hetero)multivalent CD conjugates exhibiting dual PNA/maltase 
(11), PNA/-mannosidase (11), ConA/maltase (7, 11, 12) or 
ConA/-mannosidase (12) strong recognition abilities. The -Glc 
homoglycocluster 10, although a rather modest inhibitor of -
mannosidase (Ki 351±10 M), was also evaluated in the 
ConA/-mannosidase competitive assay for comparative 
purposes. The capacities of increasing concentrations of the 
reference glycone (13 or 15), glycone/aglycone (14 or 16) or 
multivalent (5) inhibitors of maltase or -mannosidase to 
interfere in the formation of the corresponding 
glyco(mimetic)cluster-enzyme complex, as determined by the 
residual lectin cross-linking capabilities at the maximum enzyme 
concentration tested (20 U mL-1), are represented in Figure 7. 
 
Figure 7. Residual PNA–HRP-PNA (A and C) or ConA–HRP-ConA cross-
linking (B and D) mediated by the indicated glyco(mimetic)clusters  (125 M) 
in the presence of maltase (A and B) or -mannosidase (-Manase; C and D) 
at 20 U mL-1. Determinations have been conducted in the absence and in the 
presence of increasing amounts of aglycone- (13 or 15), glycone/aglycone (14 
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or 16) and multivalent-type (5) inhibitors of the enzymes. Each bar represents 
the mean of three independent determinations (S.D. 15-20%).  
The ensemble of data strengthens the idea that 
monovalent and (hetero)multivalent inhibitors target different 
sites in maltase. Thus, no competition between the glycone-type 
inhibitor 13 and multiconjugates 7, 9, 11 or 12 was observed 
(see Figure 7 A and B). Binding of the same (hetero)multivalent 
derivatives to maltase was instead very sensitive to the  
presence of the glycone/aglycone inhibitor 14 or the multivalent 
inhibitor 5. A binding mode involving the aglycone site in priority 
(for which the affinity follows the trend ONJ>>-Glc), reinforced 
by additional interactions with other nonglycone subsites (with 
the opposite affinity trend) can account for these observations 
(Figure 8 A). This mechanism agrees with the fact that the -Glc 
homoclusters 6 and 10 are no or very weak inhibitors of maltase 
and isomaltase, but can however significantly enhance the 
inihibitory potency when present in heterodisplays with ONJ 
motifs (Tables 2 and 3). The preferred implication of the 
aglycone site is also consistent with the competitive character of 
the inhibition. 
In the case of Jack bean -mannosidase two different 
scenarios were apparent. In agreement with previous 
observations, the glycone site was found to be critically involved 
in binding of ONJ homomultivalent inhibitors, since the glycone-
type inhibitor 15 was already able to efficiently restore the lectin 
cross-linking capabilities of 9 in the corresponding PNA/-
mannosidase competitive assay (Figure 7 C). A similar situation 
was encountered for the heterovalent derivative 12 (Figure 7 D). 
Nonglycone subsites probably provide additional secondary 
interactions (Figure 8 B). In sharp contrast, the reference 
glycone-type inhibitor 15 did not affect binding of the ONJ/-Glc 
statistic heteroclusters 7 (Figure 7 B) and 11 (Figure 7 C) or the 
-Glc homogeneous glycocluster 10 (Figure 7 D) to -
mannosidase. In those cases, enzyme binding was very 
sensitive to the presence of the glycone/aglycone inhibitor 16 or 
the multivalent inhibitor 5. These observations strongly suggest 
that the presence of the -Glc motif in 7, 10 and 11, but not in 12, 
elicits a shift from the binding mode entailing the glycone site to 
another one in which this site is no longer available. The 
negative heterovalent effect observed when comparing the NIRP 
values of 5 or 9 with 7 or 11 (Table 3) reflects the much lower 
efficiency of the second binding mode.  
In principle, the glycone site of a glycosidase is much more 
demanding than the aglycone or other nonglycone subsites in 
terms of the structural and architectural requirements that a 
complementary binding partner must fulfil. For instance, it is 
known that the presence of a single N-acetylglucosamine 
substituent in high mannose oligosaccharide substrates can 
totally abolish processing by Jack bean -mannosidase by 
impeding the proper orientation of the terminal -manopyranosyl 
units.[39] In the CD heteroconjugates 7 and 11 the presence of 
the -Glc units in different arms seem to exert a similar action, 
thwarting proper accommodation of the ONJ inhitope in the 
glycone site and permitting only interactions with 
aglycone/nonglycone subsites, which in practice turns off 
efficient enzyme inhibition (Figure 8 C). In case of 12, the higher 
flexibility of the dendritic architecture allows conformations in 
which the ONJ and -Glc moieties are accommodated in 
opposite space regions. In the most favourable situation, a 
symmetrical segregated distribution can be achieved, which 
might benefit from a heptavalent presentation of the ONJ 
inhitopes (like in 5) capable of multivalently interacting with the 
glycone site of -mannosidase and probably benefitting from 
additional interactions of the ONJ/-Glc motifs with other 
nonglycone subsites (Figure 8 D). 
 
Figure 8. Schematic representation of the mechanisms proposed to account 
for the inhibitory heterocluster effect. Grey and black balls represent ONJ and 
-Glc substituents, respectively. (A) In maltase or isomaltase, the glycone site 
(highlighted in black) is not accessible and interactions occur at the aglycone 
(preferentially involving ONJ moieties) and other nonglycone subsites 
(preferentially involving -Glc units). (B) The implication of the glycone site is 
critical in the inhibition of -mannosidase by ONJ homoclusters. (C) The 
presence of -Glc substituents in heteroclusters prevents accommodation of 
ONJ units in the glycone site. (D)  The dendritic architecture of heterocluster 
12 is compatible with conformations allowing favourable ONJ-glycone site 
interactions, resulting in enhanced -mannosidase inhibition. The 3D 
molecular model of 12 in the fully extended, segregated conformation is shown 
(ONJ units in light blue; -Glc units in light green; CD scaffold in orange). 
Conclusions 
Taken together, the ensemble of results here discussed 
substantiates the vision that (hetero)multivalency promotes 
binding modes that share significant analogies in both lectins 
and glycosidases. Beyond this notion, the work here presented 
demonstrates that (hetero)multivalent displays can 
simultaneously act on lectins and glycosidases in a multimodal 
manner and that a given glycotope or inhitope moiety may elicit 
different responses depending on the presence or not of a 
second, a priori innocent, glyco(mimetic) motif. By changing total 
and partial valencies and adjusting the overall topology of the 
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(hetero)multivalent construct, “on” or “off” states for a range of 
lectins and glycosidases can be activated, markedly altering the 
selectivity pattern encountered for monovalent derivatives. It is 
important to emphasize that although invoking a lectin-like 
behaviour to justify the responses of glycosidases to 
(hetero)multivalency is appealing, identifying the operating 
mechanisms is essential for a rigorous understanding. In this 
sense, the work here presented provides unique experimental 
tools for the combined analysis of (hetero)multivalent effects in 
lectin binding and glycosidase inhibition. Most importantly, it 
delivers a rational for the disturbing observation that artificial 
(hetero)multivalent carbohydrate displays, profusely investigated 
to interfere in lectin-mediated biological events, can eventually 
exhibit a priori unforeseen glycosidase inhibitory properties. 
Further work in this sense should ascertain the repercussions of 
the multimodal ligand character of (hetero)multivalent 
glyco(mimetic)clusters in biological systems. 
 
Experimental Section 
For the detailed description of the synthetic procedures, the analytical 
and spectroscopic data and the biochemical assays, see the Supporting 
Information. 
Acknowledgements 
This study was supported by the Spanish Ministerio de 
Economía y Competitividad (contract numbers SAF2016-76083-
R and CTQ2015-64425-C2-1-R), the Junta de Andalucía 
(contract number FQM2012-1467) and the European Regional 
Development Funds (FEDER and FSE). Technical assistance 
from the research support services of the University of Sevilla 
(CITIUS) is also acknowledged. 
Keywords: carbohydrates • glycomimetics • heteromultivalency 
• inhibitors • sp2-iminosugars 
[1] a) A. F. F. R. Nardy, L. Freire-de-Lima , C. G. Freire-de-Lima, A. Morrot, 
Front. Oncol. 2016, 6, 54; b) K. Ohtsubo, J. D. Marth, Cell 2006, 126, 
855-867; c) B. E. Collins, J. C. Paulson, Curr. Opin. Chem. Biol. 2004, 
8, 617-625; d) P. Albersheim, B. S. Valent, J. Cell. Biol. 1978, 78, 627-
643. 
[2] a) H.-J. Gabius, J. C. Manning. J. Kopitz, S. André, H. Kaltner, Cell. Mol. 
Life Sci. 2016, 73, 1989-2016; b) D. Solís, N. V. Bovin, A. P. Davis, J. 
Jiménez-Barbero, A. Romero, R. Roy, K. Smetana Jr., H.-J. Gabius, 
Biochim. Biphys. Acta 2015, 1850, 186-235; c) H.-J. Gabius, H. C. 
Siebert, S. André, J. Jiménez-Barbero, H. Rüdiger, ChemBioChem, 
2004, 5, 740-764. 
[3] a) G. J. Davies, A. Planas, C. Rovira, Acc. Chem. Res. 2012, 45, 308-
316; b) G. Speciale, A. J Thompson, G. J. Davies, S. J. Williams, Curr. 
Opin. Struct. Biol. 2014, 28, 1-13. 
[4] a) M. Mammen, S.-K. Choi, G. M. Whitesides, Angew. Chem. Int. Ed. 
1998, 37, 2754-2794; b) C. R. Bertozzi, L. L. Kiessling, Science 2001, 
291, 2357-2364; c) J. J. Lundquist, E. J. Toone, Chem. Rev. 2002, 102, 
555-578; d) L. L. Kiessling, J. E. Gestwicki and L. E. Strong, Angew. 
Chem., Int. Ed. 2006, 45, 2348; e) C. Fasting, C. A. Schalley, M. Weber, 
O. Seitz, S. Hecht, B. Koksch, J. Dernedde, C. Graf, E.-W. Knapp, R. 
Haag, Angew. Chem., Int. Ed. 2012, 51, 10472-10498. 
[5] For selected recent reviews on multivalent glycoarchitectures as potent 
lectin ligands, see: a) N. Spinelli, E. Defrancq, F. Morvan, Chem. Soc. 
Rev. 2013, 42, 4557-4573; b) K. Hatano, K. Matsuoka, D. Terunuma, 
Chem. Soc. Rev. 2013, 42, 4574-4598; c) M. C. Galan, P. Dumy, O. 
Renaudet, Chem. Soc. Rev. 2013, 42, 4599-4612; d) F. Sansone, A. 
Casnati, Chem. Soc. Rev. 2013, 42, 4623-4639; e) Y. M. Chabre, R. 
Roy, Chem. Soc. Rev. 2013, 42, 4657-4708; f) J.-L. Reymond, M. 
Bergmann, T.  Darbre, Chem. Soc. Rev. 2013, 42, 4814-4822. 
[6] A few monovalent glycomimetics with high affinity towards 
complementary lectins have also been developed; for a review, see: S. 
Cecioni, A. Imberty, S. Vidal, Chem. Rev. 2015, 115, 525-561. 
[7] a) R. Lahiri, A. A. Ansari, Y. D. Vankar, Chem. Soc. Rev. 2013, 42, 
5102-5118; b) T. M. Gloster, D. J. Vocadlo, Nat. Chem. Biol. 2012, 8, 
683-694; c) T. M. Wrodnigg, A. E. Stütz, Adv. Carbohydr. Chem. 
Biochem. 2011, 66, 187-298. 
[8] M. Gómez-García, J. M. Benito, D. Rodríguez-Lucena, J. Yu, K. 
Chmurski, C. Ortiz Mellet, R. Gutiérrez Gallego, A. Maestre, J. Defaye, 
J. M. García Fernández, J. Am. Chem. Soc. 2005, 127, 7970-7971. 
[9] M. Gómez-García, J. M. Benito, R. Gutiérrez-Gallego, A. Maestre, C. 
Ortiz Mellet, J. M. García Fernández, J. L. Jiménez Blanco, Org. Biomol. 
Chem. 2010, 8, 1849-1860. 
[10] M. Gómez-García, J. M. Benito, A. P. Butera, C. Ortiz Mellet, J. M. 
García Fernández, J. L. Jiménez Blanco, J. Org. Chem. 2012, 77, 
1273-1288. 
[11] D. Ponader, P. Maffre, J. Aretz, D. Pussak, N. M. Ninnemann, S. 
Schmidt, P. H. Seeberger, C. Rademacher, G. U. Nienhaus, L. 
Hartmann, J. Am. Chem. Soc. 2014, 136, 2008-2016. 
[12] L. Otten, M. I. Gibson, RSC Adv. 2015, 5, 53911-53914. 
[13] For reviews dealing with the heterocluster effect, see: a) J. L. Jiménez 
Blanco, C. Ortiz Mellet, J. M. García Fernández, Chem. Soc. Rev. 2013, 
42, 4532-4542; b) C. Müller, G. Despras, T. K. Lindhorst, Chem. Soc. 
Rev. 2016, 45, 3275-3302. 
[14] For selected recent references on the synthesis of heteroglycoclusters, 
see: a) G. C. Daskhan, C. Pifferi, O. Renaudet, Chem. Open 2016, 5, 
477-484; b) S. P. Vincent, K. Buffet, I. Nierengarten, A. Imberty, J.-F. 
Nierengarten, Chem. Eur. J. 2016, 22, 88-92; c) L. Xue, X. Xiong, Ku. 
Chen, Y. Luan, G. Chen, H. Chen, Polym. Chem., 2016, 7, 4263-4271; 
d) S. Jiang, S. Niu, Z.-H. Zhao, Z.-J. Li, Q. Li, Carbohydr. Res. 2015, 
414, 39-45; e) A. Meyer, M. Noël, J.-J. Vasseur, F. Morvan, Eur. J. Org. 
Chem. 2015, 921-2927; f) B. Thomas, M. Fiore, G. C. Daskhan, N. 
Spinelli, O. Renaudet, Chem. Commun. 2015, 51, 5436-5439; g) 
M. Fiore, G. C. Daskhan, B. Thomas O. Renaudet, Beilstein J. Org. 
Chem. 2014, 10, 1557-1563; h) B. Thomas, M. Fiore, I. Bossu, P. 
Dumy, O. Renaudet, Beilstein J. Org. Chem. 2012, 8, 421-427; i) M. 
Karskela, M. von Usedom, P. Virta, H. Lönnberg, Eur. J. Org. Chem. 
2012, 6594-6605. 
[15] P. Compain, C. Decroocq, J. Iehl, M. Holler, D. Hazelard, T. Mena 
Barragan, C. Ortiz Mellet, J. F. Nierengarten, Angew. Chem. Int. Ed. 
2010, 49, 5753-5756. 
[16] C. Decroocq, D. Rodriguez-Lucena, V. Russo, T. Mena Barragan, C. 
Ortiz Mellet, P. Compain, Chem. Eur. J. 2011, 17, 13825-13831. 
[17] R. Rísquez-Cuadro, J. M. García Fernández, J. F. Nierengarten, C. 
Ortiz Mellet, Chem. Eur. J. 2013, 19, 16791-16803. 
[18] C. Decroocq, A. Joosten, R. Sergent, T. Mena Barragán, C. Ortiz Mellet, 
P. Compain, ChemBioChem 2013, 14, 2038-2049. 
[19] A. Joosten, J. P. Schneider, M. L. Lepage, C. Tarnus, A. Bodlenner, P. 
Compain, Eur. J. Org. Chem. 2014, 1866-1872. 
[20] C. Bonduelle, J. Huang, T. Mena-Barragan, C. Ortiz Mellet, C. 
Decroocq, E. Etame, A. Heise, P. Compain, S. Lecommandoux, Chem. 
Commun. 2014, 50, 3350-3352. 
[21] a) M. Durka, K. Buffet, J. Iehl, M. Holler, J. F. Nierengarten, S. P. 
Vincent, Chem. Eur. J. 2012, 18, 641-651; b) A. Tikad, H. Fu, C. M. 
FULL PAPER    
 
 
 
 
 
Sevrain, S.Laurent, J.-F. Nierengarten, S. P. Vincent, Chem. Eur. J. 
2016, 22, 13147-13155. 
[22] For reviews, see: a) P. Compain, A. Bodlenner, ChemBioChem 2014, 
15, 1239-1251; b) S. G. Gouin, Chem. Eur. J. 2014, 20, 11616-11628; 
c) N. Kanfar, E. Bartolami, R. Zelli, A. Marra, J.-Y. Winum, S. Ulrich, P. 
Dumy, Org. Biomol. Chem. 2015, 13, 9894-9906; d) R. Zelli, J.-F. 
Longevial, P. Dumy, A. Marra, New J. Chem. 2015, 39, 5050-5074; e) 
C. Matassini, C. Parmeggian, F. Cardona, A. Goti, Tetrahedron Lett. 
2016, 57, 5407-5415. 
[23] For selected recent references on the synthesis and evaluation of 
multivalent glycosidase inhibitors, see: a) M. L. Lepage, J. P. Schneider, 
A. Bodlenner, A. Meli, F. De Riccardis, M. Schmitt, C. Tarnus, N.-T. 
Nguyen-Huynh, Y.-N. Francois, E. Leize-Wagner, C. Birck, A. Cousido-
Siah, A. Podjarny, I. Izzo, P. Compain Chem. Eur. J. 2016, 22, 5151-
5155; b) E. Laigre, D. Hazelard, J. Casas, J. Serra-Vinardell, H. 
Michelakakis, I. Mavridou, J. M. F. G. Aerts, A. Delgado, P. Compain, 
Carbohydr. Res. 2016, 429, 98-104; c) T. Hurtaux, G. Sfihi-Loualia, Y. 
Brissonnet, J. Bouckaert, J.-M. Mallet, B. Sendid, F. Delplace, E. Fabre, 
S. G. Gouin, Y. Guerardel, Carbohydr. Res. 2016, 429, 123-127; d)  F. 
Stauffert, A. Bodlenner, T. M. N. Trinh, M. I. García-Moreno, C. Ortiz 
Mellet, J.-F. Nierengarten, P. Compain, New J. Chem. 2016, 40, 7421-
7430; e) R. Zelli, E. Bartolami, J.-F. Longevial, Y. Bessin, P. Dumy, A. 
Marra, S. Ulrich, RSC Adv. 2016, 6, 2210-2216. 
[24] A. Siriwardena, M. Khanal, A. Barras, O. Bande, T. Mena-Barragan, C. 
Ortiz Mellet, J. M. García Fernández, R. Boukherroub, S. Szunerits, 
RSC Adv. 2015, 5, 100568-100578. 
[25] M. Abellán Flos, M. I. García Moreno, C. Ortiz Mellet, J. M. García 
Fernández, J.-F. Nierengarten, S. P. Vincent, Chem. Eur. J. 2016, 22, 
11450-11460. 
[26]  sp2-Iminosugars are carbohydrate mimics in which the endocyclic 
oxygen typical of monosaccharides has been replaced by a 
pseudoamide-type nitrogen atom with a high sp2-hybridation character. 
For selected recent references, see: a) E. M. Sánchez-Fernández, J. M. 
García Fernández, C. Ortiz Mellet, Chem. Commun. 2016, 52, 5497-
5515; b) T. Mena-Barragán, A. Narita, D. Matias, G. Tiscornia, E. 
Nanba, K. Ohno, Y. Suzuki, K. Higaki, J. M. García Fernández, C. Ortiz 
Mellet, Angew. Chem. Int. Ed. 2015, 54, 11696-11700; c) M. de La 
Mata, D. Cotán, M. Oropesa-Yvila, J. Garrido-Maraver, M. D. Cordero, 
M. V. Paz, A. D. Pavun, E. Alcocer-Gómez, I. de Lavera, P. Ybot-
González, A. P. Zaderenko, C. Ortiz Mellet, J. M. García Fernández, J. 
A. Sánchez-Alcázar, Sci. Rep. 2015, 5, 10903; d) M. I. García-Moreno, 
M. de la Mata, E. M. Sánchez-Fernández, J. M. Benito, A. Díaz-
Quintana, S. Fustero, E. Nanba, K. Higaki, J. A. Sánchez-Alcázar, J. M. 
García Fernández, C. Ortiz Mellet, J. Med. Chem. 2017, in press, DOI: 
10.1021/acs.jmedchem.6b01550. 
[27] A. Martínez, C. Ortiz Mellet, J. M. García Fernández, Chem. Soc. Rev. 
2013, 42, 4746-4773. 
[28] a) T. K. Lindhorst, S. Kötter, J. Kubisch, U. Krallmann-Wenzel, S. 
Ehlers, V. Kren, Eur. J. Org. Chem. 1998, 1669-1674 a) M. François-
Heude, A. Méndez-Ardoy, P. L. V. Cendret, R. Daniellou, C. Ortiz 
Mellet, J. M. García Fernández, V. Moreau, F. Djedaïni-Pilard, Chem. 
Eur. J. 2015, 21, 1978-1991; b) J. J. Cid Martín, M. Assali, E. 
Fernández-García, V. Valdivia, E. M. Sánchez-Fernández, J. M. García 
Fernandez, R. Wellinger, I. Fernandez, N. Khiar, J. Mater. Chem. B 
2016, 4, 2028-2037. 
[29] M. Almant, A. Mastouri, L. Gallego-Yerga, J. M. Garcia Fernandez, C. 
Ortiz Mellet, J. Kovensky, S. Morandat, K. El Kirat, S. G. Gouin, Chem. 
Eur. J. 2013, 19, 729-738. 
[30] a) S.-H. Kim, T. Hoshiba, T. Akaike, Biomaterials 2004, 25, 1813-1823; 
b) E. M. Aguilar Moncayo, N. Guilloteau, C. Bienvenu, J. L. Jiménez 
Blanco, C. Di Giorgio, P. Vierling, J. M. Benito, C. Ortiz Mellet, J. M. 
García Fernández, New J. Chem. 2014, 38, 5215-5225. 
[31] P. N. Kanellopoulos, K. Pavlou, A. Perrakis, B. Agianian, C. E. Vorgias, 
C. Mavrommatis, M. Soufi, P. A. Tucker, S. J. Hamodrakas, J. Struct. 
Biol. 1996, 116, 345-355. 
[32] R. Banerjee, K. Das, R. Ravishankar, K. Suguna, A. Surulia, M. Vijayan, 
J. Mol. Biol. 1996, 259, 281-296. 
[33] J. B. Corbell, J. J. Lundquist, E. J. Toone, Tetrahedron: Asymmetry 
2000, 11, 95-111. 
[34]  B. Trastoy, D. A. Bonsor, M. E. Pérez-Ojeda, M. L. Jimeno, A. Méndez-
Ardoy, J. M. García Fernández, E. J. Sundberg, J. L. Chiara, Adv. 
Funct. Mater. 2012, 22, 3191-3201. 
[35] a) K. Sasaki, Y. Nishida, T. Tsurumi, H. Uzawa, H. Kondo, K. 
Kobayashi, Angew. Chem., Int. Ed. 2002, 41, 4463-4467; b) Y. Nishida, 
H. Dohi and K. Kobayashi, Trends Glycosci. Glycotechnol. 2005, 17, 
59-69. 
[36] a) V. M. Díaz Pérez, M. I. García-Moreno, C. Ortiz Mellet, J. Fuentes, J. 
C. Díaz Arribas, F. J. Cañada, J. M. García Fernández, J. Org. Chem. 
2000, 65, 136-143; b) J. L. Jiménez Blanco, V. M. Díaz Pérez, C. Ortiz 
Mellet, F. Fuentes, J. M. García Fernández, J. C. Díaz Arribas, F. J. 
Cañada, Chem. Commun. 1997, 1969-1970. 
[37] E. M. Sánchez-Fernández, R. Rísquez-Cuadro, C. Ortiz Mellet, J. M. 
García Fernández, P. M. Nieto-Mesa, J. Angulo-Álvarez, Chem. Eur. J. 
2012, 18, 8527-8539. 
[38] E. M. Sánchez-Fernández, R. Rísquez-Cuadro, M. Aguilar-Moncayo, M. 
I. García-Moreno, C. Ortiz Mellet, J. M. García Fernández, Org. Lett. 
2009, 11, 3306-3309. 
[39] K. Dohi, J. Isoyama-Tanaka, R. Misaki, K. Fujiyama, Biochimie 2011, 
93, 766-771. 
FULL PAPER    
 
 
 
 
 
 
 
FULL PAPER 
Different selectivity patterns 
towards enzymes and lectins 
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multivalent effect. 
 
  M. I. García-Moreno, F. Ortega-
Caballero,[a] R. Rísquez-Cuadro 
C. Ortiz Mellet,* J. M. García 
Fernández* 
Page No. – Page No. 
The Impact of 
Heteromultivalency in Lectin 
Recognition and Glycosidase 
Inhibition: An Integrated 
Mechanistic Study 
 
  
 
   
 
 
